D. Trukhin - Odessa National Medical University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 49 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon,Tony Mok, Melissa L. Johnson

JOURNAL OF THORACIC ONCOLOGYno. 1 (2025): 76-93

Cited1Views0WOSBibtex

Pembrolizumab Plus Either Epacadostat or Placebo for Cisplatin-Ineligible Urothelial Carcinoma: Results from the ECHO-307/KEYNOTE-672 Study

Andrea Necchi,Michiel S. Van der Heijden,Dmytro Trukhin,Avivit Peer,Howard Gurney,Boris Y. Alekseev,Francis X. Parnis,Raya Leibowitz,Maria De Santis,Petros Grivas,Jason Clark,Mihaela Munteanu,Ritesh Kataria,Calvin Jia,Arjun V. Balar,Ronald de Wit

BMC Cancerno. 1 (2024): 1-11

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn